Dow Up0.59% Nasdaq Up0.44%

Bioanalytical Systems Inc. (BASI)

2.38 Down 0.01(0.22%) 12:59PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Bioanalytical Systems Inc.
Purdue Research Park
2701 Kent Avenue
West Lafayette, IN 47906
United States - Map
Phone: 765-463-4527
Fax: 765-497-1102

Index Membership:N/A
Industry:Research Services
Full Time Employees:150

Business Summary 

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers various services, including product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; and stability testing to establish and confirm product purity, potency, and shelf life. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; and pharmacokinetic and safety testing services, as well as provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and VetronicsÂ’ products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Bioanalytical Systems Inc.

Key Executives 
Ms. Jacqueline M. Lemke , 51
Chief Exec. Officer, Pres and Director
Mr. John P. Devine Jr., B.S., DABT, 52
VP of Toxicology
Mr. Larry S. Boulet , 67
Director, Chairman of Audit Committee and Member of Nominating/Corp. Governance Committee
Dr. A. Charlene Sullivan Ph.D., 64
Director, Chairman of Nominating/Corp. Governance Committee and Member of Audit Committee
Dr. Peter T. Kissinger Ph.D., 69
Founder and Chairman Emeritus
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders